Part 6/7:
Both Skrmetti and Ross touched on the financial interests surrounding gender-affirming treatments, suggesting that this has evolved into a multi-billion-dollar industry. Skrmetti named several states, noting that increased scrutiny and legislative measures were prompted by the realization of potentially exploitative practices in the health sector. They framed the ongoing discussion as not just a matter of law and medical ethics, but also one influenced by significant economic factors.